The FDA has issued guidance for drugmakers to establish duration limits for medically important antibiotics used in food-producing animals to combat antibiotic resistance, though critics contend it inadequately addresses human health risks. This move aims to revise labeling of about 28% of antibiotics that can currently be administered continuously without specific timelines, emphasizing the importance of clear start and stop criteria for their use. Content creators should highlight the tension between regulatory efforts and public health concerns regarding antibiotic resistance in agriculture.
Read the full article at STAT Pharma
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



